Clinical Trial: Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance
Study Status: Completed
Recruit Status: RECRUITING
Condition: Fructan Intolerance
Study Type: INTERVENTIONAL
Official Title: A Double-Blind, Placebo-Controlled, Crossover Study of Sacrosidase for the Treatment of Subjects With Fructan Intolerance
Brief Summary:
SSDXA-14 is a Phase 2 (feasibility/pilot) double-blind, placebo-controlled, crossover study to evaluate the efficacy and safety of sacrosidase and placebo in 25 subjects objectively diagnosed with fructan intolerance.
Read more